Hostname: page-component-848d4c4894-sjtt6 Total loading time: 0 Render date: 2024-06-17T01:35:58.979Z Has data issue: false hasContentIssue false
  • English
  • Français

Myopathy as the Initial Manifestation of Primary Amyloidosis

Published online by Cambridge University Press:  02 December 2014

J. Keith ,
Z. Afshar-Ghotli ,
R. Roussev ,
B. Ernst ,
B. Young  and
J. M. Bilbao
J. Keith*
Affiliation:
Department of Anatomical Pathology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto
Z. Afshar-Ghotli
Affiliation:
Department of Anatomical Pathology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto
R. Roussev
Affiliation:
Neurology, Credit Valley Hospital, North York
B. Ernst
Affiliation:
Hematology, Credit Valley Hospital, Mississauga, Ontario, Canada
B. Young
Affiliation:
Department of Anatomical Pathology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto
J. M. Bilbao
Affiliation:
Department of Anatomical Pathology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto
*
Department of Anatomical Pathology, Sunnybrook Health Sciences Centre, Room E4-32, 2075 Bayview Avenue, Toronto, Ontario, M4N 3M5, Canada
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Brief Communications
Information
Canadian Journal of Neurological Sciences , Volume 38 , Issue 1 , January 2011 , pp. 161 - 164
Copyright
Copyright © Canadian Neurological Sciences Federation 2011

References

1 Picken, MM. Amyloidosis - where are we now and where are we heading? Arch Pathol Lab Med. 2010; 134:545–51.Google Scholar
2 Westermark, P, Benson, MD, Buxbaum, JM, et al. Amyloid protein fibril nomenclature-2002. Amyloid. 2002; 9:197–200.Google Scholar
3 Desai, HV, Aronow, WS, Peterson, SJ. Cardiac amyloidosis: approaches to diagnosis and management. Cardiol Rev. 2010; 18:1–11.CrossRefGoogle ScholarPubMed
4 Bilbao, JM, Schmidt, R, Hawkins, C. Diseases of peripheral nerve. In: Love, S, Louis, DN, Ellison, DW, editors. Greenfield's Neuropathology, 8th ed. London: Hodder-Arnold; 2008. p.1675–81.Google Scholar
5 Chapin, JE, Kornfeld, M, Harris, A. Amyloid myopathy: characteristic features of a still underdiagnosed disease. Muscle Nerve. 2005; 31:266–72.CrossRefGoogle ScholarPubMed
6 Ashe, J, Borel, CO, Hart, G, Humphrey, RL, Derrick, DA, Kunel, RW. Amyloid myopathy presenting with respiratory failure. J Neurol Neurosurg Psychiatry. 1992; 55:162–5.Google Scholar
7 Nadkarni, N, Freimer, M, Mendell, JR. Amyloidosis causing a progressive myopathy. Muscle Nerve. 1995; 18:1016–8.CrossRefGoogle ScholarPubMed
8 Gertz, MA, Kyle, RA. Myopathy in primary systemic amyloidosis. J Neurol Neurosurg Psychiatry. 1996; 60:655–60.Google Scholar
9 Metzler, JP, Fleckenstein, JL, White, CL, Haller, RG, Frenkel, EP, Greenlee, RG. MRI evaluation of amyloid myopathy. Skeletal Radiol. 1992; 21:463–5.Google Scholar
10 Sheehan-Dare, RA, Simmons, AV. Amyloid myopathy and myeloma: response to treatment. Postgrad Med J. 1987; 63 (736):141–2.CrossRefGoogle ScholarPubMed
11 Spuler, S, Emslie-Smith, A, Engel, AG. Amyloid myopathy: an underdiagnosed entity. Ann Neurol. 1998; 43:719–28.Google Scholar
12 Jennekens, FG, Wokke, JH. Proximal weakness of the extremities as a main feature of amyloid myopathy. J Neurol Neurosurg Psychiatry. 1987; 50:1353–8.Google Scholar
13 Rodolico, C, Mazzeo, A, Toscano, A. Amyloid myopathy presenting with rhabdomyolysis: evidence of complement activation. Neuromuscul Disord. 1996; 16:514–7.Google Scholar